Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
Executive Summary
After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.
You may also be interested in...
Pharma Disappointed By New Extension Of EU Signal Detection Pilot
A further extension of the EU signal detection pilot means that certain drug sponsors must keep monitoring the EudraVigilance database on a continuous basis. Industry argues there is enough evidence that this activity brings no additional value, and that current requirements should be replaced with a more proportionate approach.
EU Extends Pilot Of New Drug Safety Reporting System
Testing of the enhanced EU drug safety reporting system, EudraVigilance, is to be extended beyond February in an effort to gain more information on how stakeholders are finding the new requirements.
EMA Postpones Decision On Next Phase Of EudraVigilance To End Of 2019
The European Commission has agreed to extend the ongoing signal detection pilot involving the revamped EU pharmacovigilance database and has asked for a report on experience in the first year.